Thiophosphate nucleosides for the treatment of HCV
US9339541B2 · kind B2 · utility
25Cited by
128References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 3, 2014 |
| Grant date | May 17, 2016 |
| Priority date | — |
| Expiry date | Mar 3, 2034 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are compounds, compositions and methods for the treatment of Flaviviridae infections, including HCV infections. In certain embodiments, the compounds are according to Formula 2001:where PD, Base, RA and RB are as provided herein. In certain embodiments, compounds and compositions of nucleoside derivatives are disclosed, which can be administered either alone or in combination with other anti-viral agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.